The clinical course of acute pancreatitis and the inflammatory mediators that drive it

International Journal of Inflammation

Volumn 2012, Issue , 2012, Pages

  Kylänpää, Leena ^a   Rakonczay, Zoltán ^b   O'Reilly, Derek A ^c,d  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF SZEGED   (Hungary)

^c NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; DROTRECOGIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; IMIPENEM; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; LEXIPAFANT; MACROPHAGE INFLAMMATORY PROTEIN 1; MEROPENEM; MONOCYTE CHEMOTACTIC PROTEIN 1; PEFLOXACIN; PLACEBO; PROBIOTIC AGENT; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR INHIBITOR;

ACUTE PANCREATITIS; ANTIBIOTIC PROPHYLAXIS; BACTEROIDES INFECTION; CANDIDIASIS; CAUSE OF DEATH; CLINICAL EFFECTIVENESS; CONSERVATIVE TREATMENT; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ESCHERICHIA COLI INFECTION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTION PREVENTION; INFECTION RISK; INFECTIOUS PANCREATIC NECROSIS; INTESTINE ISCHEMIA; MULTIPLE ORGAN FAILURE; NONHUMAN; OUTCOME ASSESSMENT; PERCUTANEOUS DRAINAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEPSIS; SEPTIC SHOCK; STAPHYLOCOCCUS INFECTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84876509805     PISSN: 20908040     EISSN: 20420099     Source Type: Journal    
DOI: 10.1155/2012/360685     Document Type: Review

References (124)

1. Pandol S. J., Saluja A. K., Imrie C. W., Banks P. A., Acute pancreatitis: bench to the bedside. Gastroenterology 2007 132 3 1127 1151 2-s2.0-33947318807 10.1053/j.gastro.2007.01.055 (Pubitemid 46440879)
2. Sah R. P., Saluja A., Molecular mechanisms of pancreatic injury. Current Opinion in Gastroenterology 2011 27 5 444 451 10.1097/MOG.0b013e328349e346
3. Saluja A. K., Lerch M. M., Phillips P. A., Dudeja V., Why does pancreatic overstimulation cause pancreatitis? Annual Review of Physiology 2007 69 249 269 2-s2.0-33947376068 10.1146/annurev.physiol.69.031905.161253 (Pubitemid 46457643)
4. Rakonczay Z. Jr., Hegyi P., Takács T., McCarroll J., Saluja A. K., The role of NF- B activation in the pathogenesis of acute pancreatitis. Gut 2008 57 2 259 267 2-s2.0-38549084647 10.1136/gut.2007.124115 (Pubitemid 351158056)
5. Mayerle J., Dummer A., Sendler M., Malla S. R., van den Brandt C., Teller S., Aghdassi A., Nitsche C., Lerch M. M., Differential roles of inflammatory cells in pancreatitis. Journal of Gastroenterology and Hepatology 2012 27 supplement 2 47 51 10.1111/j.1440-1746.2011.07011.x
6. Bradley E. III, A clinically based classification system for acute pancreatitis: summary of the international symposium on acute pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Archives of Surgery 1993 128 5 586 590 2-s2.0-0027254390
7. Bollen T. L., Santvoort H., Besselink M. G., van Leeuwen M. S., Horvath K. D., Freeny P. C., Gooszen H. G., on behalf of the Dutch Acute Pancreatitis Study Group, The Atlanta classification of acute pancreatitis revisited. British Journal of Surgery 2008 95 1 6 21 2-s2.0-38549093298 10.1002/bjs.6010 (Pubitemid 351184911)
8. Dellinger E. P., Forsmark C. E., Layer P., Lévy P., Maraví-Poma E., Petrov M. S., Shimose-gawa T., Siriwardena A. K., Uomo G., Whitcomb D. C., Windsor J. A., Pancreatitis Across Nations Clinical Research and Education Alliance (PANCREA), Determinant-based classification of acute pancreatitis severity: an international multidisciplinary consultation. Annals of Surgery 2012 256 6 875 880 10.1097/SLA.0b013e318256f778
9. Vincent J. L., Moreno R., Takala J., Willatts S., de Mendonça A., Bruining H., Reinhart C. K., Suter P. M., Thijs L. G., The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Medicine 1996 22 7 707 710 2-s2.0-0030015661 10.1007/s001340050156 (Pubitemid 26254283)
10. Johnson C. D., Kingsnorth A. N., Imrie C. W., McMahon M. J., Neoptolemos J. P., McKay C., Toh S. K. C., Skaife P., Leeder P. C., Wilson P., Larvin M., Curtis L. D., Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. Gut 2001 48 1 62 69 2-s2.0-0035159658 10.1136/gut.48.1.62 (Pubitemid 32042643)
11. Isenmann R., Rau B., Beger H. G., Early severe acute pancreatitis: characteristics of a new subgroup. Pancreas 2001 22 3 274 278 2-s2.0-0035087672 10.1097/00006676-200104000-00008 (Pubitemid 32242493)
12. Mentula P., Kylänpää-Bäck M. L., Kemppainen E., Takala A., Jansson S. E., Kautiainen H., Puolakkainen P., Haapiainen R., Repo H., Decreased HLA (human leucocyte antigen)-DR expression on peripheral blood monocytes predicts the development of organ failure in patients with acute pancreatitis. Clinical Science 2003 105 4 409 417 2-s2.0-0141923125 10.1042/CS20030058 (Pubitemid 37249166)
13. Kox W. J., Volk T., Kox S. N., Volk H. D., Immunomodulatory therapies in sepsis. Intensive Care Medicine 2000 26 1, supplement S124 S128 2-s2.0-0034108730 (Pubitemid 30184503)
14. Halonen K. I., Pettilä V., Leppäniemi A. K., Kemppainen E. A., Puolakkainen P. A., Haapiainen R. K., Multiple organ dysfunction associated with severe acute pancreatitis. Critical Care Medicine 2002 30 6 1274 1279 2-s2.0-0036272972 (Pubitemid 34620971)
15. McKay C. J., Evans S., Sinclair M., Carter C. R., Imrie C. W., High early mortality rate from acute pancreatitis in Scotland, 1984-1995. British Journal of Surgery 1999 86 10 1302 1305 2-s2.0-0032821402 10.1046/j.1365-2168.1999. 01246.x (Pubitemid 29481540)
16. Buter A., Imrie C., Carter C., Evans S., McKay C., Dynamic nature of early organ dys-function determines outcome in acute pancreatitis. British Journal of Surgery 2002 89 3 298 302 10.1046/j.0007-1323.2001.02025.x (Pubitemid 34227027)
17. Johnson C. D., Abu-Hilal M., Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis. Gut 2004 53 9 1340 1344 2-s2.0-4344688989 10.1136/gut.2004.039883 (Pubitemid 39120123)
18. Brivet F. G., Emilie D., Galanaud P., The Parisian Study Group on Acute Pancreatitis, Pro- and anti-inflammatory cytokines during acute severe pancreatitis: an early and sustained response, although unpredictable of death. Critical Care Medicine 1999 27 4 749 755 2-s2.0-0032939769 10.1097/00003246- 199904000-00029 (Pubitemid 29218208)
19. Nowak A., Marek T. A., Nowakowska-Duława E., Rybicka J., Kaczor R., Biliary pancreatitis needs endoscopic retrograde cholangiopancreatography with endoscopic sphincterotomy for cure. Endoscopy 1998 30 9 A256 A259 2-s2.0-0032199881
20. Marik P. E., Zaloga G. P., Meta-analysis of parenteral-nutrition versus enteral nutrition in patients with acute pancreatitis. British Medical Journal 2004 328 7453 1407 1410 2-s2.0-2942741071 (Pubitemid 38789192)
21. Petrov M. S., van Santvoort H. C., Besselink M., van der Heijden G., Windsor J. A., Gooszen H. G., Enteral nutrition and the risk of mortality and infectious complications in patients with severe acute pancreatitis: a meta-analysis of randomized trials. Archives of Surgery 2008 143 11 1111 1117 2-s2.0-56549098403 10.1001/archsurg.143.11.1111
22. O'Reilly D. A., Kingsnorth A. N., Management of acute pancreatitis: role of antibiotics remains controversial. British Medical Journal 2004 328 7446 968 969 2-s2.0-1942532032
23. Tenner S., Antibiotics in patients with pancreatic necrosis: the controversy continues. American Journal of Gastroenterology 2007 102 5 1127 2-s2.0-34247847625 10.1111/j.1572-0241.2007.01180-1.x (Pubitemid 46698242)
24. Beger H., Bittner R., Block S., Büchler M., Bacterial contamination of pancreatic necrosis. Gastroenterology 1986 91 2 433 438
25. Bassi C., Falconi M., Talamini G., Uomo G., Papaccio G., Dervenis C., Salvia R., Minelli E. B., Pederzoli P., Controlled clinical trial of pefloxacin versus imipenem in severe acute pancreatitis. Gastroenterology 1998 115 6 1513 1517 2-s2.0-0031731213 (Pubitemid 28546002)
26. Götzinger P., Wamser P., Barlan M., Sautner T., Jakesz R., Függer R., Candida infection of local necrosis in severe acute pancreatitis is associated with increased mortality. Shock 2000 14 3 320 323 2-s2.0-0034278112
27. Isenmann R., Rünzi M., Kron M., Kahl S., Kraus D., Jung N., Maier L., Malfertheiner P., Goebell H., Beger H. G., German Antibiotics in Severe Acute Pancreatitis Study Group, Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial. Gastroenterology 2004 126 4 997 1004 2-s2.0-11144355326 10.1053/j.gastro.2003.12.050 (Pubitemid 38451171)
28. Dellinger E. P., Tellado J. M., Soto N. E., Ashley S. W., Barie P. S., Dugernier T., Imrie C. W., Johnson C. D., Knaebel H. P., Laterre P. F., Maravi-Poma E., Kissler J. J. O., Sanchez-Garcia M., Utzolino S., Early antibiotic treatment for severe acute necrotizing pancreatitis: a randomized, double-blind, placebo-controlled study. Annals of Surgery 2007 245 5 674 683 2-s2.0-34247636183 10.1097/01.sla.0000250414.09255.84 (Pubitemid 46684095)
29. Besselink M. G. H., van Santvoort H. C., Buskens E., Boermeester M. A., van Goor H., Timmerman H. M., Nieuwenhuijs V. B., Bollen T. L., van Ramshorst B., Witteman B. J., Rosman C., Ploeg R. J., Brink M. A., Schaapherder A. F., Dejong C. H., Wahab P. J., van Laarhoven C. J., van der Harst E., van Eijck C. H., Cuesta M. A., Akkermans L. M., Gooszen H. G., Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. The Lancet 2008 371 9613 651 659 2-s2.0-39449089584 10.1016/S0140-6736(08)60207-X
30. Kivisaari L., Somer K., Strandertskjöld-Nordenstam C., Early detection of acute fulminant pancreatitis by contrast-enhanced computed tomography. Scandinavian Journal of Gastroenterology 1983 18 1 39 41 2-s2.0-0020691170 (Pubitemid 13138100)
31. de Beaux A. C., Palmer K. R., Carter D. C., Factors influencing morbidity and mortality in acute pancreatitis; an analysis of 279 cases. Gut 1995 37 1 121 126 2-s2.0-0029010010
32. Tenner S., Sica G., Hughes M., Noordhoek E., Feng S., Zinner M., Banks P. A., Relationship of necrosis to organ failure in severe acute pancreatitis. Gastroenterology 1997 113 3 899 903 2-s2.0-0030874833 10.1016/S0016-5085(97) 70185-9 (Pubitemid 27381150)
33. Remes-Troche J. M., Uscanga L. F., Peláez-Luna M., Duarte-Rojo A., González-Balboa P., Teliz M. A., Chan-Nunez C., Campuzano M., Robles-Díaz G., When should we be concerned about pancreatic necrosis? Analysis from a single institution in Mexico City. World Journal of Surgery 2006 30 12 2227 2233 2-s2.0-33845364591 10.1007/s00268-006-0148-8 (Pubitemid 44885179)
34. Working Party of the British Society of Gastroenterology; Association of Surgeons of Great Britain and Ireland; Pancreatic Society of Great Britain and Ireland; Association of Upper GI Surgeons of Great Britain and Ireland, UK guidelines for the management of acute pancreatitis. Gut 2005 54 supplement 3 1 9
35. Toouli J., Brooke-Smith M., Bassi C., Carr-Locke D., Telford J., Freeny P., Imrie C., Tandon R., Working Party of the Program Commitee of the Bangkok World Congress of Gastroenterology, Guidelines for the management of acute pancreatitis. Journal of Gastroenterology and Hepatology 2002 17 supplement 1 S15 S39 2-s2.0-0036104069 10.1046/j.1440-1746.17.s1.2.x (Pubitemid 34539295)
36. Raraty M. G. T., Halloran C. M., Dodd S., Ghaneh P., Connor S., Evans J., Sutton R., Neoptolemos J. P., Minimal access retroperitoneal pancreatic necrosectomy: improvement in morbidity and mortality with a less invasive approach. Annals of Surgery 2010 251 5 787 793 2-s2.0-77951665315 10.1097/SLA.0b013e3181d96c53
37. van Santvoort H. C., Besselink M. G., Bakker O. J., Hofker H. S., Boermeester M. A., Dejong C. H., van Goor H., Schaapherder A. F., van Eijck C. H., Bollen T. L., van Ramshorst B., Nieuwenhuijs V. B., Timmer R., Laméris J. S., Kruyt P. M., Manusama E. R., van der Harst E., van der Schelling G. P., Karsten T., Hesselink E. J., van Laarhoven C. J., Rosman C., Bosscha K., de Wit R. J., Houdijk A. P., van Leeuwen M. S., Buskens E., Gooszen H. G., A step-up approach or open necrosectomy for necrotizing pancreatitis. The New England Journal of Medicine 2010 362 16 1491 1502 2-s2.0-77951434634 10.1056/NEJMoa0908821
38. de Waele J. J., Leppäniemi A. K., Intra-abdominal hypertension in acute pancreatitis. World Journal of Surgery 2009 33 6 1128 1133 10.1007/s00268-009-9994-5
39. Steer M., Meldolesi J., Pathogenesis of acute pancreatitis. Annual Review of Medicine 1988 39 95 105 328579 10.1146/annurev.me.39.020188.000523 (Pubitemid 19090786)
40. Otani T., Chepilko S. M., Grendell J. H., Gorelick F. S., Codistribution of TAP and the granule membrane protein GRAMP-92 in rat caerulein-induced pancreatitis. American Journal of Physiology 1998 275 5 G999 G1009 2-s2.0-0031767879
41. Singh V. P., Saluja A. K., Bhagat L., van Acker G. J. D., Song A. M., Soltoff S. P., Cantley L. C., Steer M. L., Phosphatidylinositol 3-kinase-dependent activation of trypsinogen modulates the severity of acute pancreatitis. The Journal of Clinical Investigation 2001 108 9 1387 1395 2-s2.0-0035179805 10.1172/JCI200112874 (Pubitemid 33107767)
42. Gukovskaya A. S., Gukovsky I., Autophagy and pancreatitis. American Journal of Physiology 2012 303 9 G993 G1003 10.1152/ajpgi.00122.2012
43. Gukovsky I., Pandol S. J., Mareninova O. A., Shalbueva N., Jia W., Gukovskaya A. S., Impaired autophagy and organellar dysfunction in pancreatitis. Journal of Gastroenterology and Hepatology 2012 27 supplement 2 27 32
44. Grasso D., Ropolo A., Lo Ré A., Boggio V., Molejón M. I., Iovanna J. L., Gonzalez C. D., Urrutia R., Vaccaro M. I., Zymophagy, a novel selective autophagy pathway mediated by VMP1-USP9x-p62, prevents pancreatic cell death. The Journal of Biological Chemistry 2011 286 10 8308 8324 2-s2.0-79953144994 10.1074/jbc.M110.197301
45. Booth D. M., Mukherjee R., Sutton R., Criddle D. N., Calcium and reactive oxygen species in acute pancreatitis. Friend or foe? Antioxidants & Redox Signaling 2011 15 10 2683 2698 10.1089/ars.2011.3983
46. Rau B. M., Krüger C. M., Schilling M. K., Anti-cytokine strategies in acute pancreatitis: pathophysiological insights and clinical implications. Roczniki Akademii Medycznej w Białymstoku 2005 50 106 115 2-s2.0-33644829101
47. Gullo L., Migliori M., Oláh A., Farkas G., Levy P., Arvanitakis C., Lankisch P., Beger H., Acute pancreatitis in five European countries: etiology and mortality. Pancreas 2002 24 3 223 227 2-s2.0-0036205356 10.1097/00006676-200204000-00003 (Pubitemid 34260645)
48. Hegyi P., Rakonczay Z. Jr., The role of nitric oxide in the physiology and pathophysiology of the exocrine pancreas. Antioxidants & Redox Signaling 2011 15 2723 2741 10.1089/ars.2011.4063
49. Escobar J., Pereda J., López-Rodas G., Sastre J., Redox signaling and histone acetylation in acute pancreatitis. Free Radical Biology and Medicine 2012 52 5 819 837 10.1016/j.freeradbiomed.2011.11.009
50. Bone R. C., Balk R. A., Cerra F. B., Dellinger R. P., Fein A. M., Knaus W. A., Schein R. M. H., Sibbald W. J., Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992 101 6 1644 1655 2-s2.0-0026710191
51. Montravers P., Chollet-Martin S., Marmuse J. P., Gougerot-Pocidalo M. A., Desmonts J. M., Lymphatic release of cytokines during acute lung injury complicating severe pancreatitis. American Journal of Respiratory and Critical Care Medicine 1995 152 5 I 1527 1533 2-s2.0-0028793960 (Pubitemid 3002089)
52. Malmstrøm M. L., Hansen M. B., Andersen A. M., Ersbøll A. K., Nielsen O. H., Jørgensen L. N., Novovic S., Cytokines and organ failure in acute pancreatitis: inflammatory response in acute pancreatitis. Pancreas 2012 41 2 271 277 10.1097/MPA.0b013e3182240552
53. Castell J. V., Gomez-Lechon M. J., David M., Andus T., Geiger T., Trullenque R., Fabra R., Heinrich P. C., Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Letters 1989 242 2 237 239 2-s2.0-0024581491 10.1016/0014-5793(89)80476-4 (Pubitemid 19020112)
54. Repo H., Harlan J. M., Mechanisms and consequences of phagocyte adhesion to endothelium. Annals of Medicine 1999 31 3 156 165 2-s2.0-0032972640 (Pubitemid 29304453)
55. Menger M. D., Plusczyk T., Vollmar B., Microcirculatory derangements in acute pancreatitis. Journal of Hepato-Biliary-Pancreatic Surgery 2001 8 3 187 194 10.1007/s005340170015 (Pubitemid 33690536)
56. Foitzik T., Eibl G., Hotz B., Hotz H., Kahrau S., Kasten C., Schneider P., Buhr H. J., Persistent multiple organ microcirculatory disorders in severe acute pancreatitis. Experimental findings and clinical implications. Digestive Diseases and Sciences 2002 47 1 130 138 2-s2.0-0036145135 10.1023/A: 1013284008219 (Pubitemid 34075029)
57. Lasson A., Ohlsson K., Consumptive coagulopathy, fibrinolysis and protease-antiprotease interactions during acute human pancreatitis. Thrombosis Research 1986 41 2 167 183 2-s2.0-0022650352 (Pubitemid 16165692)
58. Lasson A., Ohlsson K., Disseminated intravascular coagulation and antiprotease activity in acute human pancreatitis. Scandinavian Journal of Gastroenterology 1986 126 35 39 2-s2.0-0022823910 (Pubitemid 17216609)
59. Okamura D., Starr M. E., Lee E. Y., Stromberg A. J., Evers B. M., Saito H., Age-dependent vulnerability to experimental acute pancreatitis is associated with increased systemic inflammation and thrombosis. Aging Cell 2012 11 5 760 769 10.1111/j.1474-9726.2012.00841.x
60. Lindström O., Kylänpää L., Mentula P., Puolakkainen P., Kemppainen E., Haapiainen R., Fernandez J. A., Griffin J. H., Repo H., Petaja J., Upregulated but insufficient generation of activated protein C is associated with development of multiorgan failure in severe acute pancreatitis. Critical Care 2006 10 1, article R16 2-s2.0-33846028402 10.1186/cc3966 (Pubitemid 47079805)
61. Salomone T., Tosi P., Palareti G., Tomassetti P., Migliori M., Guariento A., Saieva C., Raiti C., Romboli M., Gullo L., Coagulative disorders in human acute pancreatitis: role for the D-dimer. Pancreas 2003 26 2 111 116 2-s2.0-0037373873 10.1097/00006676-200303000-00003 (Pubitemid 36278294)
62. Shen L., Dahlback B., Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa. The Journal of Biological Chemistry 1994 269 29 18735 18738 2-s2.0-0028290275 (Pubitemid 24226180)
63. Murakami K., Okajima K., Uchiba M., Johno M., Nakagaki T., Okabe H., Takatsuki K., Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production. American Journal of Physiology 1997 272 2, part 1 L197 L202 2-s2.0-0030909690
64. Joyce D. E., Gelbert L., Ciaccia A., DeHoff B., Grinnell B. W., Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. The Journal of Biological Chemistry 2001 276 14 11199 11203 2-s2.0-0035815747 10.1074/jbc.C100017200 (Pubitemid 38089304)
65. Bone R., Sir Isaac Newton, sepsis, SIRS, and CARS. Critical Care Medicine 1996 24 7 1125 1128 10.1097/00003246-199607000-00010 (Pubitemid 26249361)
66. Mentula P., Kylänpää M. L., Kemppainen E., Jansson S. E., Sarna S., Puolakkainen P., Haapiainen R., Repo H., Plasma anti-inflammatory cytokines and monocyte human leucocyte antigen-DR expression in patients with acute pancreatitis. Scandinavian Journal of Gastroenterology 2004 39 2 178 187 2-s2.0-10744228831 10.1080/00365520310008278 (Pubitemid 38253632)
67. Mayer J. M., Rau B., Siech M., Beger H. G., Local and systemic zymogen activation in human acute pancreatitis. Digestion 2000 62 2-3 164 170 2-s2.0-0033760940 10.1159/000007809
68. de Beaux A. C., Fearon K. C. H., Circulating endotoxin, tumour necrosis factor-alpha, and their natural antagonists in the pathophysiology of acute pancreatitis. Scandinavian Journal of Gastroenterology 1996 31 219 43 46 2-s2.0-0030330378 (Pubitemid 26261804)
69. Simovic M. O., Bonham M. J. D., Abu-Zidan F. M., Windsor J. A., Anti-inflammatory cytokine response and clinical outcome in acute pancreatitis. Critical Care Medicine 1999 27 12 2662 2665 2-s2.0-0033396419 (Pubitemid 30027177)
70. Chen C. C., Wang S. S., Lu R. H., Chang F. Y., Lee S. D., Serum interleukin 10 and interleukin 11 in patients with acute pancreatitis. Gut 1999 45 6 895 899 2-s2.0-0032758196
71. Mentula P., Kylänpää M. L., Kemppainen E., Jansson S. E., Sarna S., Puolakkainen P., Haapiainen R., Repo H., Early prediction of organ failure by combined markers in patients with acute pancreatitis. British Journal of Surgery 2005 92 1 68 75 2-s2.0-12444279000 10.1002/bjs.4786 (Pubitemid 40144197)
72. Hershman M. J., Appel S. H., Wellhausen S. R., Sonnenfeld G., Polk H. C., Interferon-gamma treatment increases HLA-DR expression on monocytes in severely injured patients. Clinical and Experimental Immunology 1989 77 1 67 70 2-s2.0-0024348520 (Pubitemid 19198815)
73. Döcke W. D., Randow F., Syrbe U., Krausch D., Asadullah K., Reinke P., Volk H. D., Kox W., Monocyte deactivation in septic patients: restoration by IFN- γ treatment. Nature Medicine 1997 3 6 678 681 2-s2.0-0030917203 10.1038/nm0697-678 (Pubitemid 27264980)
74. Opal S. M., DePalo V. A., Anti-inflammatory cytokines. Chest 2000 117 4 1162 1172 2-s2.0-0034090602 (Pubitemid 30228378)
75. Fumeaux T., Pugin J., Role of interleukin-10 in the intracellular sequestration of human leukocyte antigen-DR in monocytes during septic shock. American Journal of Respiratory and Critical Care Medicine 2002 166 11 1475 1482 2-s2.0-0036892751 10.1164/rccm.200203-217OC (Pubitemid 35387298)
76. Wolk K., Döcke W. D., von Baehr V., Volk H. D., Sabat R., Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 2000 96 1 218 223 2-s2.0-0342626639 (Pubitemid 30456474)
77. Dinarello C. A., Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. International Reviews of Immunology 1998 16 5-6 457 499 10.3109/08830189809043005 (Pubitemid 28286181)
78. Garcia-Sabrido J. L., Valdecantos E., Bastida E., Tellado J. M., The anergic state as a predictor of pancreatic sepsis. Zentralblatt für Chirurgie 1989 114 2 114 120 2-s2.0-0024548647 (Pubitemid 19055847)
79. Kylänpää-Bäck M. L., Takala A., Kemppainen E., Puolakkainen P., Kautiainen H., Jansson S. E., Haapiainen R., Repo H., Cellular markers of systemic inflammation and immune suppression in patients with organ failure due to severe acute pancreatitis. Scandinavian Journal of Gastroenterology 2001 36 10 1100 1107 2-s2.0-0034871154 10.1080/ 003655201750422738 (Pubitemid 32801698)
80. Richter A., Nebe T., Wendl K., Schuster K., Klaebisch G., Quintel M., Lorenz D., Post S., Trede M., HLA-DR expression in acute pancreatitis. European Journal of Surgery 1999 165 10 947 951 2-s2.0-0032717881 10.1080/ 110241599750008053 (Pubitemid 29503060)
81. Li Q., Wang C., Zhang Q., The role of sphingosine kinase 1 in patients with severe acute pancreatitis. Annals of Surgery 2012 255 5 954 962 10.1097/SLA.0b013e31824d2ca4
82. de Beaux A. C., Goldie A. S., Ross J. A., Carter D. C., Fearon K. C. H., Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. British Journal of Surgery 1996 83 3 349 353 2-s2.0-0029992055 10.1002/bjs.1800830317 (Pubitemid 26083168)
83. McKay C. J., Gallagher G., Brooks B., Imrie C. W., Baxter J. N., Increased monocyte cytokine production in association with systemic complications in acute pancreatitis. British Journal of Surgery 1996 83 7 919 923 2-s2.0-0029978482 10.1002/bjs.1800830712 (Pubitemid 26228204)
84. Ogawa M., Acute pancreatitis and cytokines: 'second attack' by septic complication leads to organ failure. Pancreas 1998 16 3 312 315 2-s2.0-0031919812
85. Lundberg A. H., Granger D. N., Russell J., Sabek O., Henry J., Gaber L., Kotb M., Gaber A. O., Quantitative measurement of P- and E-selectin adhesion molecules in acute pancreatitis: correlation with distant organ injury. Annals of Surgery 2000 231 2 213 222 2-s2.0-0033950393 10.1097/00000658-200002000-00010 (Pubitemid 30078804)
86. Büchler M., Friess H., Uhl W., Beger H., Clinical relevance of experimental acute pancreatitis. European Surgical Research 1992 24 supplement 1 85 88
87. Foitzik T., Hotz H. G., Eibl G., Buhr H. J., Experimental models of acute pancreatitis: are they suitable for evaluating therapy? International Journal of Colorectal Disease 2000 15 3 127 135 2-s2.0-0033834483 10.1007/s003840000216
88. Malleo G., Mazzon E., Siriwardena A. K., Cuzzocrea S., TNF- α as a therapeutic target in acute pancreatitis-lessons from experimental models. The Scientific World Journal 2007 7 431 448 2-s2.0-34047226686 10.1100/tsw.2007.98 (Pubitemid 46536397)
89. Grewal H., Mohey el Din A., Gaber L., Kotb M., Gaber A., Amelioration of the physiologic and biochemical changes of acute pancreatitis using an anti-TNF-alpha polyclonal antibody. The American Journal of Surgery 1994 167 1 214 218 10.1016/0002-9610(94)90076-0 (Pubitemid 24264167)
90. Malleo G., Mazzon E., Genovese T., Di Paola R., Muià C., Centorrino T., Siriwardena A. K., Cuzzocrea S., Etanercept attenuates the development of cerulein-induced acute pancreatitis in mice: a comparison with TNF- α genetic deletion. Shock 2007 27 5 542 551 2-s2.0-34047232622 10.1097/01.shk.0000246900.50445.1d (Pubitemid 46626082)
91. Guice K. S., Oldham K. T., Remick D. G., Kunkel S. L., Ward P. A., Anti-tumor necrosis factor antibody augments edema formation in caerulein-induced acute pancreatitis. Journal of Surgical Research 1991 51 6 495 499 2-s2.0-0026334287 10.1016/0022-4804(91)90171-H
92. Ghezzi P., Cerami A., Tumor necrosis factor as a pharmacological target. Molecular Biotechnology 2005 31 3 239 244 2-s2.0-26844484550 10.1385/MB:31:3:239 (Pubitemid 41456757)
93. Qiu P., Cui X., Barochia A., Li Y., Natanson C., Eichacker P. Q., The evolving experience with therapeutic TNF inhibition in sepsis: considering the potential influence of risk of death. Expert Opinion on Investigational Drugs 2011 20 11 1555 1564 10.1517/13543784.2011.623125
94. Norman J., Franz M., Messina J., Riker A., Fabri P. J., Rosemurgy A. S., Gower W. R., Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery 1995 117 6 648 655 2-s2.0-0029020932 10.1016/S0039-6060(95)80008-5
95. van Laethem J. L., Marchant A., Delvaux A., Goldman M., Robberecht P., Velu T., Devière J., Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology 1995 108 6 1917 1922 2-s2.0-0029011858 10.1016/0016-5085(95)90158-2
96. Osman M. O., Jacobsen N. O., Kristensen J. U., Deleuran B., Gesser B., Larsen C. G., Jensen S. L., IT9302, a synthetic interleukin-10 agonist diminishes acute lung injury in rabbits with acute necrotizing pancreatitis. Surgery 1998 124 3 584 592 2-s2.0-0031668057 10.1016/S0039-6060(98)70106-0 (Pubitemid 28413357)
97. Paszkowski A. S., Rau B., Mayer J. M., Möller P., Beger H. G., Therapeutic application of caspase 1/interleukin-1 β -converting enzyme inhibitor decreases the death rate in severe acute experimental pancreatitis. Annals of Surgery 2002 235 1 68 76 2-s2.0-0036141077 10.1097/00000658-200201000- 00009 (Pubitemid 34062401)
98. Osman M. O., Kristensen J. U., Jacobsen N. O., Lausten S. B., Deleuran B., Deleuran M., Gesser B., Matsushima K., Larsen C. G., Jensen S. L., A monoclonal anti-interleukin 8 antibody (WS-4) inhibits cytokine response and acute lung injury in experimental severe acute necrotising pancreatitis in rabbits. Gut 1998 43 2 232 239 2-s2.0-15444354781 (Pubitemid 28348327)
99. Werner J., Z'graggen K., Fernández-del Castillo C., Lewandrowski K. B., Compton C. C., Warshaw A. L., Specific therapy for local and systemic complications of acute pancreatitis with monoclonal antibodies against ICAM-1. Annals of Surgery 1999 229 6 834 840 2-s2.0-0033497465 10.1097/00000658- 199906000-00010 (Pubitemid 30191733)
100. Frossard J. L., Saluja A., Bhagat L., Hong Sik Lee, Bhatia M., Hofbauer B., Steer M. L., The role of intercellular adhesion molecule 1 and neutrophils in acute pancreatitis and pancreatitis-associated lung injury. Gastroenterology 1999 116 3 694 701 2-s2.0-0033044628 (Pubitemid 29106778)
101. Lundberg A. H., Fukatsu K., Gaber L., Callicutt S., Kotb M., Wilcox H., Kudsk K., Gaber A. O., Blocking pulmonary ICAM-1 expression ameliorates lung injury in established diet-induced pancreatitis. Annals of Surgery 2001 233 2 213 220 2-s2.0-0035138816 10.1097/00000658-200102000-00010 (Pubitemid 32106075)
102. Foitzik T., Faulhaber J., Hotz H. G., Kirchengast M., Buhr H. J., Endothelin receptor blockade improves fluid sequestration, pancreatic capillary blood flow, and survival in severe experimental pancreatitis. Annals of Surgery 1998 228 5 670 675 2-s2.0-0032470695 10.1097/00000658-199811000-00006 (Pubitemid 30198311)
103. Eibl G., Forgacs B., Hotz H. G., Buhr H. J., Foitzik T., Endothelin A but not endothelin B receptor blockade reduces capillary permeability in severe experimental pancreatitis. Pancreas 2002 25 2 e15 e20 2-s2.0-17044442144
104. Kingsnorth A. N., Galloway S. W., Formela L. J., Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis. British Journal of Surgery 1995 82 10 1414 1420 2-s2.0-0028876181 10.1002/bjs.1800821039
105. McKay C. J., Curran F., Sharples C., Baxter J. N., Imrie C. W., Prospective placebo-controlled randomized trial of lexipafant in predicted severe acute pancreatitis. British Journal of Surgery 1997 84 9 1239 1243 2-s2.0-0030852362 10.1002/bjs.1800840912 (Pubitemid 27400271)
106. Werner J., Hartwig W., Hackert T., Kaiser H., Schmidt J., Gebhard M. M., Büchler M. W., Klar E., Multidrug strategies are effective in the treatment of severe experimental pancreatitis. Surgery 2012 151 3 372 381 10.1016/j.surg.2011.07.041
107. Uomo G., Lesson from acute experimental pancreatitis: multidrug strategies is effective than single-target therapy. Journal of the Pancreas 2012 13 5 543 544
108. Wilson P., Manji M., Neoptelos J., Acute pancreatitis as a model of sepsis. Journal of Antimicrobial Chemotherapy 1998 41 supplement 1 51 63 10.1093/jac/41.suppl-1.51 (Pubitemid 28062145)
109. Fisher C. J. Jr., Yan S. B., Protein C levels as a prognostic indicator of outcome in sepsis and related diseases. Critical Care Medicine 2000 28 9 S49 S56 10.1097/00003246-200009001-00011
110. White B., Livingstone W., Murphy C., Hodgson A., Rafferty M., Smith O. P., An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia. Blood 2000 96 12 3719 3724 2-s2.0-0034548822
111. Bernard G. R., Vincent J. L., Laterre P. F., LaRosa S. P., Dhainaut J. F., Lopez-Rodriguez A., Steingrub J. S., Garber G. E., Helterbrand J. D., Ely E. W., Fisher C. J., Efficacy and safety of recombinant human activated protein C for severe sepsis. The New England Journal of Medicine 2001 344 10 699 709 2-s2.0-0035826096 10.1056/NEJM200103083441001 (Pubitemid 32204987)
112. Abraham E., Laterre P. F., Garg R., Levy H., Talwar D., Trzaskoma B. L., François B., Guy J. S., Brückmann M., Rea-Neto Á.., Rossaint R., Perrotin D., Sablotzki A., Arkins N., Utterback B. G., Macias W. L., Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. The New England Journal of Medicine 2005 353 13 1332 1341 2-s2.0-25444492831 10.1056/NEJMoa050935 (Pubitemid 41362701)
113. Ranieri V. M., Thompson B. T., Barie P. S., Dhainaut J. F., Douglas I. S., Finfer S., Gårdlund B., Marshall J. C., Rhodes A., Artigas A., Payen D., Tenhunen J., Al-Khalidi H. R., Thompson V., Janes J., Macias W. L., Vangerow B., Williams M. D., PROWESS-SHOCK Study Group, Drotrecogin alfa (activated) in adults with septic shock. The New England Journal of Medicine 2012 366 2055 2064 10.1056/NEJMoa1202290
114. Alsfasser G., Warshaw A. L., Thayer S. P., Antoniu B., Laposata M., Lewandrowski K. B., Fernández-del Castillo C., Decreased inflammation and improved survival with recombinant human activated protein C treatment in experimental acute pancreatitis. Archives of Surgery 2006 141 7 670 676 2-s2.0-33746086050 10.1001/archsurg.141.7.670 (Pubitemid 44079829)
115. Babu B. I., Genovese T., Mazzon E., Riccardi L., Paterniti I., Galuppo M., Crisafulli C., Siriwardena A. K., Cuzzocrea S., Recombinant human activated protein C, (Xigris) attenuated murine cerulein-induced acute pancreatitis via regulation of nuclear factor B and apoptotic pathways. Pancreas 2012 41 4 619 628
116. Pettilä V., Kylänpää M. L., Leppäniemi A., Tallgren M., Markkola A., Puolakkainen P., Repo H., Kemppainen E., Kyhälä L., APCAP-activated protein C in acute pancreatitis: a double-blind randomized human pilot trial. Critical Care 2010 14 4, article R139 2-s2.0-77954885617 10.1186/cc9203
117. Kylänpää M. L., Mentula P., Kemppainen E., Puolakkainen P., Aittomäki S., Sil-vennoinen O., Haapiainen R., Repo H., Monocyte anergy is present in patients with severe acute pancreatitis and is significantly alleviated by GM-CSF and IFN-gamma in vitro. Pancreas 2005 31 1 23 27 10.1097/01.mpa.0000164449.23524.94 (Pubitemid 40911498)
118. Nierhaus A., Montag B., Timmler N., Frings D. P., Gutensohn K., Jung R., Schneider C. G., Pothmann W., Brassel A. K., Schulte Am Esch J., Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis. Intensive Care Medicine 2003 29 4 646 651 2-s2.0-0037397030 (Pubitemid 36523683)
119. Meisel C., Schefold J. C., Pschowski R., Baumann T., Hetzger K., Gregor J., Weber-Carstens S., Hasper D., Keh D., Zuckermann H., Reinke P., Volk H. D., Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. American Journal of Respiratory and Critical Care Medicine 2009 180 7 640 648 2-s2.0-70349469854 10.1164/rccm.200903-0363OC
120. Norman J., The role of cytokines in the pathogenesis of acute pancreatitis. The American Journal of Surgery 1998 175 1 76 83 2-s2.0-0031984853 10.1016/S0002-9610(97)00240-7 (Pubitemid 28047037)
121. Messmann H., Vogt W., Holstege A., Lock G., Heinisch A., von Fürstenberg A., Leser H. G., Zirngibl H., Schölmerich J., Post-ERP pancreatitis as a model for cytokine induced acute phase response in acute pancreatitis. Gut 1997 40 1 80 85 2-s2.0-0031050280 (Pubitemid 27079755)
122. O'Reilly D. A., Roberts J. R., Cartmell M. T., Demaine A. G., Kingsnorth A. N., Heat shock factor-1 and nuclear factor-kappaB are systemically activated in human acute pancreatitis. Journal of the Pancreas 2006 7 2 174 184 2-s2.0-33644990747
123. Oiva J., Mustonen H., Kylänpää M. L., Kyhälä L., Alanärä T., Aittomäki S., Siitonen S., Kemppainen E., Puolakkainen P., Repo H., Patients with acute pancreatitis complicated by organ failure show highly aberrant monocyte signaling profiles assessed by phospho-specific flow cytometry. Critical Care Medicine 2010 38 8 1702 1708 2-s2.0-77954957019 10.1097/CCM.0b013e3181e7161c
124. Oiva J., Mustonen H., Kylänpää M. L., Kyhälä L., Kuuliala K., Siitonen S., Kemppainen E., Puolakkainen P., Repo H., Acute pancreatitis with organ dysfunction associates with abnormal blood lymphocyte signaling: controlled laboratory study. Critical Care 2010 14 6, article R207 2-s2.0-78349255047 10.1186/cc9329